Josh Enomoto

Josh Enomoto

Brokering multi-million-dollar deals with some of the world’s biggest companies and providing in-depth marketing analyses, Josh Enomoto takes his firsthand knowledge of the corporate boardroom and delivers them across several media outlets. In addition to his work at InvestorPlace, Josh contributes content for Benzinga, TipRanks, EmergingGrowth and Blockster. He is also a guest expert at CGTN America.

While leaving no stone unturned regarding sector coverage, Josh has written extensively about cryptocurrencies. You can follow him on Blockster, a crypto-centric social media platform and on LinkedIn.

Recent Articles

IBIO Stock May Have a Longer ‘Trial Period’

One of the few beneficiaries of the coronavirus are pharmaceutical firms that may offer a solution. But with IBIO stock and similar names, the upside pathway may not be as limited as previously thought.

CCL Stock Is Staring at a Very Bleak Future

Due to coronavirus fears causing major disruptions to the cruise liner industry, CCL stock naturally suffered huge losses. But the volatility may not be over due to severe sector and branding damages.

Chesapeake Energy Stock Is Past Due for Its Execution Date

Prior to the coronavirus, CHK stock was an extremely risky play. With it devolving into a pandemic, Chesapeake is simply doomed.

President Trump Will Nuke Alibaba Stock If It Comes to That

In September 2019, President Trump toyed with the idea of delisting Alibaba stock and other Chinese publicly traded companies. Now in the year of the coronavirus, this idea has far more significance.

9 Recession-Proof Stocks to Disinfect the Coronavirus

As the coronavirus pandemic worsens, stable but boring recession-proof stocks to buy are suddenly in vogue. Here are the nine picks that might ride this black swan even to profitability.